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Abstract
Background:  With the completion of the whole genome sequence for many organisms,
investigations into genomic structure have revealed that gene distribution is variable, and that genes
with similar function or expression are located within clusters. This clustering suggests that there
are evolutionary constraints that determine genome architecture. However, as most of the
evidence for constraints on genome evolution comes from studies on yeast, it is unclear how much
of this prior work can be extrapolated to mammalian genomes. Therefore, in this work we wished
to examine the constraints on regions of the mammalian genome containing conserved gene
clusters.
Results: We first identified regions of the mouse genome with microsynteny conservation by
comparing gene arrangement in the mouse genome to the human, rat, and dog genomes. We then
asked if any particular gene types were found preferentially in conserved regions. We found a
significant correlation between conserved microsynteny and the density of mouse orthologs of
human disease genes, suggesting that disease genes are clustered in genomic regions of increased
microsynteny conservation.
Conclusion: The correlation between microsynteny conservation and disease gene locations
indicates that regions of the mouse genome with microsynteny conservation may contain
undiscovered human disease genes. This study not only demonstrates that gene function constrains
mammalian genome organization, but also identifies regions of the mouse genome that can be
experimentally examined to produce mouse models of human disease.
Background
The availability of several mammalian genome sequences
has enabled comparative genomic studies to identify
regions of conserved linkage among different organisms
(reviewed in [1-4]). These studies have been used to pre-
dict the genome architecture of the common mammalian
ancestor [5,6], as well as to assess recombination [7,8] and
genome evolution [9]. Additionally, regulatory elements
have been identified by the characterization of conserved
regions of non-coding DNA [10-12]. Non-coding func-
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tional RNAs and microRNA targets have also been identi-
fied through comparative genomic approaches [3,13,14].
Gene function may be inferred from conserved proteins in
other species. Likewise, comparative genomics among
mammalian species is useful for predicting the functional
consequences of mutations in human disease loci [15-
18]. Additionally, mapping genes responsible for quanti-
tative traits in rodents allows the prediction of locations of
human quantitative traits underlying disease, based on
conserved genomic structure between rodents and
humans [19-22].
Although it is becoming increasingly apparent that
genomes display a large degree of structural plasticity,
there are nevertheless significant evolutionary constraints
on genome structure. Previous studies have provided evi-
dence for functional constraints on genome organization
in prokaryotic and eukaryotic genomes [23]. Studies in
yeast demonstrate that essential genes are found in
genomic clusters [24]. The clustering of essential genes in
yeast is likely driven by selection for reduced noise in gene
expression levels, as essential gene clusters are localized in
regions of open chromatin [25]. Additionally, in the nem-
atode C. elegans, essential genes are located in clusters in
regions with low recombination [26].
Clustering of genes with similar functions has also been
observed in mammalian genomes. In the human genome,
genes that are in the same pathway are in closer proximity
than would be expected by chance [27]. Similarly, in the
mouse genome, genes with common GO annotations are
found in clusters [28]. This is not due to tandem duplica-
tions, as most genes in the same pathway that are adjacent
in the genome do not arise from duplication events [27].
It is possible that functionally related genes are located in
clusters to facilitate coordinated transcription, as many
genes in clusters are co-expressed [27].
Many of the previous studies to detect gene clustering
were based on bioinformatic analysis of genome annota-
tion. However, there is also support for functional con-
straints on mammalian genome organization from
experimental data. Analysis of saturation levels of mouse
mutagenesis screens for lethal phenotypes directed at spe-
cific genomic regions demonstrated that mouse essential
genes are disproportionately found in regions of con-
served microsynteny [29], at least for the small number of
genomic regions evaluated. To build on this prior work,
we assessed microsynteny conservation on all mouse
autosomes. By examining gene content in conserved and
divergent genomic regions we found a significant correla-
tion between microsynteny conservation and the density
of mouse genes that are orthologous to human disease
genes. As the mouse is widely used to model human dis-
ease [1,30], the identification of this correlation will facil-
itate the creation of new mouse models of human disease
by identifying regions of the mouse genome that contain
a high density of disease gene orthologs.
Results
Microsynteny conservation of mouse autosomes
We evaluated the level of microsynteny conservation
between the mouse genome and those of human, dog and
rat. First, we obtained all protein-coding genes and their
genomic locations on all mouse autosomes as annotated
in the Ensembl mouse genome browser [3,31] (release
50). We also obtained protein-coding genes from the
human [32,33], rat [2], and dog [34] genomes. These were
chosen because they had a sufficient level of assembly and
annotation to allow comparison. The use of the dog
genome as an outgroup to human, rat, and mouse
improves the stringency of the study [35]. To identify
orthologs of mouse genes in the other genomes, along
with their genomic locations, Ensembl BioMart homol-
ogy filters were used to compile a list of orthologous
genes.
Although the four mammalian genomes chosen are those
with the best available annotation, the degree and quality
of annotation may vary somewhat between species. In
order to control for this we took additional steps to find
the human, rat, and dog orthologs of mouse genes. Pro-
tein sequences of all mouse genes that did not have an
annotated ortholog in another species were searched
using BLAT [36] against the other genomes to identify
orthologous sequences in the other genomes. To allow a
moderately strict search with a limited number of false
positives, all hits with E-value < 10-5 were retrieved. The
genomic location of the best BLAT match in the other
genome was used for the evaluation of microsynteny con-
servation. We searched a total of 6173 genes in at least one
other species, finding an ortholog for 1210 of the genes in
other genomes. A sensitivity analysis demonstrates that
the number of genes retrieved from the BLAT searches is
relatively insensitive to the choice of E-value cut-off, as
changing the cut-off point from 10-3 to 10-7 results in 1266
- 1169 ortholog annotations respectively. Therefore, uti-
lizing alternate E-value cut-off points in this range would
have changed the annotation of only 0.48% of the total
mouse genes analyzed in our study.
Genes were defined as having conserved microsynteny if
their orthologs had the same two orthologous neighbor-
ing genes in all four species examined. Each mouse gene
was queried to determine whether it met these criteria for
conserved microsynteny. We then assessed the level of
conservation for segments of the mouse genome, deter-
mining the percentage of conserved genes in each seg-
ment. We examined 20 Mb regions of the mouse genome,
as genomic regions of this size have been analyzed exper-BMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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imentally through region-specific mutagenesis [37-40].
Thus, the identification of additional genomic regions
with conserved microsynteny will be useful for further
experimental functional genomic annotation.
We found that the conservation of microsynteny varied
throughout the mouse genome. The average percentage of
genes with conserved microsynteny in a 20 Mb interval
was 38.29%, with a standard deviation of 11.81%. The
Shapiro-Wilk test was applied to non-overlapping 20 Mb
windows to determine whether the distribution of gene
microsynteny was normal. A P-value of 0.16 indicated
that the null hypothesis (a normal distribution) should
not be rejected. However, the use of non-overlapping 20
Mb windows restricted the resolution of the study. For
example, chromosome 19 has only two observations from
non-overlapping windows. To improve the resolution of
our study, we next examined 20 Mb intervals staggered by
5 Mb. This sliding window analysis allowed more obser-
vations on each chromosome.
As the data conformed to a normal distribution, we there-
fore calculated Z-scores (number of standard deviations
above or below the mean) for each 20 Mb sliding win-
dow. Windows with Z>1 were considered to have
increased conservation, those with Z<-1 were considered
to have decreased conservation, and windows with 1>Z>-
1 had intermediate conservation. There were 51 sliding
windows of the mouse genome found to have Z>1, indic-
ative of higher microsynteny conservation, and 91 inter-
vals found to have Z<-1, indicative of lower microsynteny
conservation. Three hundred twenty-two genomic regions
demonstrate intermediate microsynteny conservation
with scores of 1>Z>-1. On individual chromosomes there
is variation in the conservation of microsynteny, with
most chromosomes containing both windows of
increased microsynteny conservation and windows of
decreased microsynteny conservation (Figure 1 black
lines). However, mouse chromosomes 5, 7, 8, 10, 13, 14,
16 and 18 do not contain any regions of increased (Z>1)
microsynteny conservation. We found that the percentage
of genes with conserved microsynteny per chromosome
also showed variation, with chromosome 13 having the
lowest percentage of conserved genes at 25%, and chro-
mosome 15 having the highest percentage of conserved
genes at 48% (Table 1). Previous work has shown that
syntenic conservation is not simply related to gene density
[29].
Comparison with sequence-based synteny blocks
We compared our results from to the sequence-based syn-
teny blocks presented for pair-wise genome alignments on
the Ensembl genome browser. For each region of the
mouse genome with increased microsynteny conserva-
tion, we identified the syntenic region of the dog, rat, and
human genome (Table 2, see Additional file 1). Most of
the conserved mouse regions identified based on
microsynteny also show conservation with a single region
in the rat based on sequence. For the intervals on mouse
chromosome 2 from 115 - 140 Mb, mouse chromosome
3 from 45 - 65 Mb, mouse chromosome 4 from 30 - 65
Mb, mouse chromosome 9 from 40 - 70 Mb, and mouse
chromosome 15 from 65 - 103 Mb, the breakpoints of
synteny in the mouse genome as compared to dog and
human genome are the same, showing evolutionary con-
servation of genome rearrangements. In a separate study
directly comparing dog and human synteny blocks, all of
these regions were found to be syntenic between dog and
human [41]. Although the region from 0 - 20 Mb on
mouse chromosome 6 is the only region entirely con-
served as a sequence-based synteny block in all three other
genomes, it is not the most highly conserved region based
on microsynteny in the mouse genome.
Conserved genes are located next to other conserved genes
Although there is variation in the density of genes with
conserved microsynteny across the genome, it is possible
that this variation merely represents random variation
within a normal distribution. To determine whether the
genomic arrangement of genes with conserved microsyn-
teny is random, we calculated the likelihood that a gene
with syntenic conservation is found next to another gene
with syntenic conservation. We then compared this to the
frequency of conserved-synteny neighbors in a set of
10,000 randomized genomes. In each of the randomized
genomes the number and position of genes is maintained,
but the annotation of conservation is randomly shuffled.
We find that the frequency of co-occurrence of genes with
conserved microsynteny is significantly non-random (Fig-
ure 2A, P < 0.003). By our definition, for a gene to have
conserved microsynteny it must have two orthologous
neighbors in all genomes examined. Thus, a pair of genes
with conserved micro-synteny represents a larger block of
conserved synteny. The finding that there are conserved
microsynteny blocks in the genome that extend beyond
groups of several genes suggests that there are constraints
on genome evolution that influence gene arrangement, as
the placement of conserved genes significantly differs
from a random distribution.
Distribution of mouse orthologs of human disease-related 
genes
As we found that conserved genes were more likely to
have conserved genes as neighbors, we investigated
whether any other groups of genes were found preferen-
tially in regions of the genome with conserved microsyn-
teny. One group of genes that are of interest is disease
genes, as they are highly relevant to human health. We
therefore performed a genome-wide analysis of the mouseBMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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The correlation between microsynteny and density of orthologs of disease-related genes on mouse autosomes Figure 1
The correlation between microsynteny and density of orthologs of disease-related genes on mouse autosomes. 
The relationship between conserved microsynteny (black) and density of mouse genes orthologous to human disease-related 
genes (blue) is shown for all mouse autosomes. Percentage of genes with conserved microsynteny and those with disease-
related orthologs are calculated for a 20 Mb sliding window, offset by steps of 5 Mb. At each position the Z-score is plotted at 
the center of the sliding window. Pearson's correlation coefficient and P-values for the analysis of co-localization of conserved 
microsyteny and disease gene orthologs are given for each chromosome. The results of a randomization of the disease genes 
(red) demonstrate that there is no correlation between microsynteny (black) and random assignment of gene status.
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orthologs of human disease-related genes to assess
whether they were found at a greater density in conserved
regions of the mouse genome. We identified human genes
with a disease-associated mutant allele from the OMIM
Morbid Map database, and cross-referenced them to the
mouse genome using Ensembl BioMart to identify mouse
orthologs. Using the genomic locations of the mouse
orthologs of human disease genes from our study on
microsyntenty conservation, we determined the propor-
tion of human disease gene orthologs in each 20 Mb slid-
ing window of the mouse genome. The mean percentage
of disease-related gene orthologs as compared to the
number of total genes in a 20 Mb interval is 7.68%, with
a standard deviation of 2.72%. We found variation in the
distribution of disease gene orthologs in the mouse
genome, with the highest percentage found on chromo-
some 18, and the lowest on chromosome 7 (Table 1).
However, on all other autosomes, 7 - 8% of the genes are
orthologs of human disease genes.
Table 1: Variation of microsynteny and disease gene density on all mouse autosomes.
Chromosome Total
Genes
Conserved
Genes
Percentage
conserved
Disease
Genes
Percentage
Disease
11 1 8 6 4 8 6 4 1 % 9 8 8 %
2 1846 696 38% 123 7%
3 996 379 38% 82 8%
41 2 8 9 5 9 1 4 6 % 9 5 7 %
5 1219 428 35% 100 8%
61 1 2 8 4 1 8 3 7 % 9 1 8 %
7 1867 650 35% 111 6%
81 0 5 1 3 6 4 3 5 % 8 9 8 %
91 2 1 9 4 8 1 3 9 % 8 6 7 %
10 978 321 33% 75 8%
11 1674 734 44% 122 7%
12 651 213 33% 49 8%
13 786 199 25% 66 8%
14 772 279 36% 55 7%
15 780 374 48% 65 8%
16 658 237 36% 46 7%
17 1019 369 36% 67 7%
18 495 192 39% 48 10%
19 725 318 44% 50 7%
Total for all autosomes 20339 7729 38% 1518 7%BMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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Table 2: Comparison of regions with Z>1 microsynteny to sequence-based synteny blocks.
Mouse Micro-synteny Interval Dog Sequence Synteny Blocks Rat Sequence Synteny Blocks Human Sequence Synteny 
Blocks
Chr1 60 - 90 Mb 60 - 80 Mb = Chr37: 14.6 - 32.7 
Mb,
80 - 90 Mb = Chr25: 40.6 - 48.1 
Mb
60 - 85 Mb = Chr9: 58.5 - 84.4 Mb,
87 Mb - 90 Mb = Chr9: 84.2 - 87.0 
Mb
60 - 90 Mb = Chr2: 203.6 - 234.6
Chr1 120 - 145 Mb 120 - 132 = Chr19: 31.4 - 43.3 Mb
132 - 133 Mb = Chr7: 8.7 - 9.3 Mb,
133 - 136 Mb = Chr38: 3.0 - 5.6 
Mb,
136 - 140 Mb = Chr7: 3.0 - 7.1 Mb
120 - 145 Mb = Chr13: 30.9 - 57.8 
Mb
120 - 132 Mb = Chr2: 125.6 - 138.4 
Mb,
132 - 145 Mb = Chr1: 193.0 - 207.7 
Mb
Chr1 155 - 175 Mb 155 - 168 Mb = Chr7: 19.4 - 33.9 
Mb,
169 - 175 Mb = Chr38: 20.0 - 25.5 
Mb
155 - 175 Mb = Chr13: 68.2 - 89.3 
Mb
155 - 175 Mb = Chr1: 159.2 - 182.9 
Mb
Chr2 45 - 85 Mb 45 - 53 Mb = Chr19: 52.6 - 56.7 
Mb,
54 - 84 Mb = Chr36: 3.8 - 32.4 Mb,
84 - 85 Mb = Chr18: 41.4 - 41.9 
Mb
45 - 85 Mb = Chr3: 25.6 - 68.4 Mb 45 - 84 Mb = Chr2: 145.2 - 188.3 
Mb,
84 - 85 Mb = Chr11: 56.9 - 57.5 Mb
Chr2 115 - 140 Mb 115 - 127 = Chr30: 7.1 - 19.7 Mb,
127 - 129 Mb = Chr17: 37.5 - 40.1 
Mb,
129 - 140 Mb = Chr24: 22.0 - 11.7 
Mb
115 - 140 Mb = Chr3: 101.6 - 128.3 
Mb
115 - 126 Mb = Chr15: 36.8 - 51.2 
Mb,
126 - 127 Mb = Chr2: 95.6 - 97.0 
Mb,
127 - 129 Mb = Chr2: 110.8 - 113.5 
Mb,
129 - 140 Mb = Chr20: 1.4 - 13.8 
Mb
Chr3 15 - 35 Mb 15 - 16 Mb = Chr24: 22.4 - 22.5 
Mb,
16 - 19 Mb = Chr29: 16.2 - 18.7 
Mb,
19 - 20 Mb = Chr23: 46.7 - 47.0 Mb
21 - 30 Mb = Chr34: 43.5 - 37.0 Mb
31 - 35 Mb = Chr34: 15.5 - 18.8 
Mb
15 - 35 Mb = Chr2: 87.0 - 122.2 
Mb
15 - 16 Mb = Chr20: 1.5 - 1.6 Mb,
16 - 19 Mb = Chr8: 64.0 - 67.0 Mb,
19 - 20 Mb = Chr3: 148.4 - 148.8 
Mb,
20 - 35 Mb = Chr3: 176.7 - 182.5 
Mb
Chr3 45 - 65 Mb 45 - 51 Mb = Chr19: 5.8 - 11.6 Mb,
52 - 55 Mb = Chr25: 3.5 - 8.0 Mb,
57 - 65 Mb = Chr23: 47.2 - 53.1 
Mb
45 - 65 Mb = Chr2: 132.8 - 155.1 
Mb
45 - 52 Mb = Chr4: 134.0 - 140.8 
Mb,
52 - 55 Mb = Chr13: 36.0 - 41.1 
Mb,
57 - 65 Mb = Chr3: 149.0 - 156.2 
Mb
Chr3 55 - 75 Mb 55 - 57 Mb = Chr25: 7.6 - 8.0 Mb,
57 - 67 Mb = Chr23: 47.2 - 55.0 
Mb,
67 - 75 Mb = Chr34: 28.0 - 35.3 
Mb
55 - 75 Mb = Chr2: 144.4 - 166.1 
Mb
55 - 57 Mb = Chr13: 36.0 - 36.3 
Mb,
57 - 75 Mb = Chr3: 149.0 - 167.1 
Mb
Chr4 30 - 65 Mb 30 - 35 Mb = Chr12: 52.6 - 49.6 
Mb,
35 - 65 Mb = Chr11: 48.5 - 73.2 
Mb
30 - 65 Mb = Chr5: 48.2 - 82.0 Mb 30 - 34 Mb = Chr6: 87.8 - 93.9 Mb,
34 - 45 Mb = Chr9: 27.3 - 38.4 Mb,
46 - 65 Mb = Chr9: 100.1 - 119.1 
MbBMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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Disease gene orthlogs are located next to other disease 
gene orthologs
As we had found that the distribution of genes with con-
served microsynteny is non-random, we examined
whether that was also true for genes with disease-related
orthologs. Using a similar approach, we calculated the
number of mouse orthologs of human disease genes with
at least one disease gene ortholog as a neighbor. As a con-
trol, we randomized which genes were annotated as dis-
ease orthologs, keeping the same total number of disease
gene orthologs. From 10,000 random trails we found that
the mouse orthologs of human disease genes were signif-
icantly more likely to have other disease gene orthologs as
neighbors (Figure 2B, P < 0.07). This finding demon-
Chr4 105 - 125 Mb 105 - 107 Mb = Chr5: 57.1 - 58.9 
Mb,
107 - 118 Mb = Chr15: 11.6 - 19.9 
Mb,
118 - 125 Mb = Chr15: 3.2 - 7.9 
Mb
105 - 125 Mb = Chr5: 127.3 - 144.8 
Mb
105 - 125 Mb = Chr1: 37.2 - 55.5 
Mb
Chr6 0 - 20 Mb 0 - 13 Mb = Chr14: 21.6 - 30.2 Mb
13 - 20 Mb - Chr14: 55.2 - 55.9 Mb
0 - 20 Mb = Chr4: 28.1 - 44.7 Mb 0 - 20 Mb = Chr7: 92.7 - 117.8 Mb
Chr9 40 - 70 Mb 40 - 54 Mb = Chr5: 13.7 - 27.7 Mb,
54 - 70 Mb = Chr30: 19.8 - 27.0 
Mb
40 - 70 Mb = Chr8: 43.2 - 74.6 Mb 40 - 54 Mb = Chr11: 107.4 - 123.4 
Mb,
54 - 70 Mb = Chr15: 59.4 - 78.3 Mb
Chr11 60 - 90 Mb 60 - 72 Mb = Chr5: 33.1 - 44.6 Mb,
72 - 90 Mb = Chr9: 33.3 - 51.0 Mb
60 - 90 Mb = Chr10: 46.4 - 78.6 
Mb
60 - 76 Mb = Chr17: 1.1 - 17.7 Mb,
76 - 90 Mb = Chr17: 28.8 - 53.4 
Mb
Chr11 100 - 120 Mb 100 - 120 Mb = Chr9: 3.6 - 24.5 Mb 100 - 120 Mb = Chr10: 89.0 - 109.7 
Mb
100 - 104 Mb = Chr17: 39.6 - 45.2 
Mb,
104 - 105 Mb = Chr7: 128.0 - 128.1 
Mb,
106 - 120 Mb = Chr17: 60.5 - 79.2 
Mb
Chr12 55 - 105 Mb 55 - 72 Mb = Chr8: 15.7 - 31.0 Mb,
72 - 102 Mb = Chr8: 36.6 - 65.4 
Mb,
102 - 104 Mb = Chr8: 3.9 - 5.1 Mb,
104 - 105 Mb = Chr8: 65.4 - 66.4 
Mb
55 - 105 Mb = Chr6: 74.3 - 127.9 
Mb
55 - 72 Mb = Chr14: 34.2 - 52.3 
Mb,
72 - 105 Mb = Chr14: 58.7 - 94.8 
Mb
Chr15 65 - 104 Mb 65 - 76 Mb = Chr13: 31.6 - 41.2 
Mb,
77 - 89 Mb = Chr10: 19.5 - 31.6 
Mb,
89 - 104 Mb = Chr27: 3.8 - 18.6 Mb
65 - 104 Mb = Chr7: 103.1 - 142.6 
Mb
65 - 76 Mb = Chr8: 132.9 - 146.2 
Mb
77 - 89 Mb = Chr22: 36.0 - 51.2 
Mb
89 - 104 Mb = Chr12: 33.5 - 54.9 
Mb
Chr17 65 - 95 Mb 65 - 66 Mb = Chr3: 4.6 - 5.2 Mb,
66 - 72 Mb = Chr7: 72.2 - 78.8 Mb,
72 - 84 Mb = Chr17: 25.8 - 37.3 
Mb,
84 - 90 Mb = Chr10: 48.4 - 54.8 
Mb,
91 - 95 Mb = Chr7: 70.7 - 72.3 Mb
65 - 72 Mb = Chr9: 103.9 - 110.8 
Mb,
72 - 77 Mb = Chr6: 17.9 - 24.1 Mb,
77 - 93 Mb = Chr6: 0.9 - 17.8 Mb,
93 - 95 Mb = Chr9: 110.7 - 112.5 
Mb
65 - 66 Mb = Chr5: 109.2 - 110.0 
Mb,
66 - 71 Mb = Chr18: 2.5 - 9.8 Mb,
72 - 93 Mb = Chr2: 29.0 - 51.2 Mb,
94 - 95 Mb = Chr18: 0.9 - 2.5 Mb
Chr19 30 - 65 Mb 30 - 34 Mb = Chr26: 38.4 - 41.9 
Mb,
34 - 65 Mb = Chr28: 7.3 - 32.4 Mb
30 - 65 Mb = Chr1: 233.7 - 267.8 
Mb
30 - 32 Mb = Chr10: 51.9 - 54.5 
Mb,
32 - 65 Mb = Chr10: 89.2 - 121.2 
Mb
Sequence-based synteny blocks were identified from the Ensembl genome browser. The intervals are listed according to positions in the mouse 
genome, with the positions of synteny in the other genomes listed following the "=" sign. The specific region of synteny in the other species is listed 
following the chromosome number and a ':'. Forward to forward alignments are show in normal text, forward to reverse alignments are shown in 
italics.
Table 2: Comparison of regions with Z>1 microsynteny to sequence-based synteny blocks. (Continued)BMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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strates that the distribution of orthologs of human disease
genes in the mouse genome is not random.
Correlation between microsynteny conservation and 
disease gene distribution
We next assessed whether the orthologs of disease genes
were located in regions of the mouse genome with
increased microsynteny conservation. We detect a correla-
tion between regions of the genome with conserved
microsynteny and the distribution of disease gene
orthologs over the whole genome (Figure 3A, Pearson's R
= 0.90, P < 1 × 10-6). Such a representation over-estimates
the true correlation between the two sets, since gene den-
sity varies considerably in different windows. This con-
founds the analysis as regions with high gene density
would be expected to have both high numbers of disease
orthologs and high numbers of genes with conserved
microsynteny regardless of whether there is an additional
correlation between microsynteny conservation and the
presence of disease gene orthologs. When corrected for
gene density, a significant correlation between microsyn-
teny conservation and disease gene ortholog density is
still observed (Figure 3B, Pearson's R = 0.40, P < 4.0 × 10-
4).
The density of disease gene orthologs for each genomic
region is shown in Figure 1 (blue lines). Z-scores are dis-
played to allow direct comparison between microsynteny
conservation and disease orthologs. The additional calcu-
lation of Z-scores does not change the overall correlation.
There is a significant correlation (P = 0.05) between
microsynteny conservation and the density of disease
gene orthologs for 12 of the 19 mouse autosomes. Thus,
genomic regions with a high percentage of genes with con-
served microsynteny also have a high percentage of dis-
ease gene orthologs. The chromosome with the best
correlation between conserved microsynteny and density
of disease gene orthologs is mouse chromosome 13, while
the chromosome with the worst correlation is mouse
chromosome 10.
To demonstrate that this correlation was not an artifact of
our analysis, we randomized the annotation of disease
genes. We assigned alternate genes as orthologs of human
disease genes, keeping the total number of disease genes
per chromosome the same as the first analysis. We then
recalculated the percentage of alternate disease genes as
compared to total genes in each sliding window through-
out the genome, and the average and standard deviation
for each sliding window. We plotted the Z-scores for each
window containing these alternate disease orthologs, and
compared them to the Z-scores for microsynteny conser-
vation (Figure 1 red lines). When the chromosomal posi-
tions of orthologs of disease genes are changed to random
locations, the correlation with microsynteny disappears
(Pearson's R = 0.02, P < 0.58). As an additional control,
we also randomized disease genes while retaining the
same number of observed disease gene pairs for each
chromosome. Again, we found no correlation (Pearson's
R = 0.004, P < 0.93). Should the correlation between
observed disease gene ortholog distribution and
microsynteny conservation be an artifact of our method-
ology, we would also expect the randomized annotations
to be correlated. This is not the case, demonstrating that
the link between microsynteny correlation and density of
disease gene orthologs does not arise from an artifact of
the methodology.
Robustness to changes in window size
To determine if the correlation we observed between
microsynteny conservation and disease gene ortholog
Conserved genes and disease genes are not randomly distrib- uted throughout the mouse genome Figure 2
Conserved genes and disease genes are not randomly 
distributed throughout the mouse genome. Panel A: 
Conserved genes are found to have conserved genes as 
neighbors more often than expected if gene position was ran-
dom. The results of 10,000 randomization trials are shown in 
the histogram, while the observed data (number of con-
served genes with at least one conserved neighboring gene) is 
shown with the red line. Panel B: Disease genes neighbor 
other disease genes more often than expected by chance. 
The results of 10,000 randomization trials are shown in the 
histogram, while the observed data (number of disease genes 
with at least one disease gene as a neighbor) is shown with 
the red line.
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density was affected by the window size used in our anal-
ysis, we repeated our assays using additional window
sizes. We chose to analyze window sizes of 10 Mb, 5 Mb,
2 Mb, and 1 Mb, with a stagger of one-quarter of the win-
dow size. We found that there was also a significant corre-
lation between regions with conserved microsynteny and
a high density of disease gene orthologs for window sizes
of 10 Mb, 5 Mb, 2 Mb, and 1 Mb (all p < 1 × 10-10, Table
3, see Additional file 2). A repeat of our randomization
test shows that this correlation is not significant when
genes are randomly annotated for window sizes of 10 Mb,
5 Mb, and 2 Mb. However, with the small window sizes of
2 mb and 1 Mb, many genomic windows do not contain
any annotated genes (Table 4), so these windows artifi-
cially show a correlation between microsynteny conserva-
tion and disease gene density, because 0 genes of either
There is a significant correlation between microsynteny and density of disease-gene orthologs over the mouse genome as a  whole. Figure 3
There is a significant correlation between microsynteny and density of disease-gene orthologs over the mouse 
genome as a whole. Panel A: The number of conserved genes plotted against the number of disease genes for 20 Mb sliding 
windows of the mouse genome. Note the fit with the regression line (Pearson's R = 0.90, P < 1 × 10-6). Panel B: The relation-
ship between the proportion of genes with conserved microsynteny (number of conserved genes per window/total genes per 
window) and the proportion of genes with disease orthologs (number of disease-related genes/total genes per window). The 
correlation for the whole mouse genome is significant (Pearson's R = 0.40, P < 4.0 × 10-4).
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
"
 
#
$
￿
￿
%
￿
&
’
￿
#
￿
$
(
￿
￿
)
*
#
&
 
)
+
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
,
￿
 
(
 
￿
-
*
 
#
 
!
"
 
#
$
￿
￿
%
￿
&
’
￿
#
￿
$
(
￿
￿
)
*
#
&
 
)
.
.
/
0
.
/
1
.
/
2
.
/
3
.
/
4
.
/
5
.
/
6
.
/
7
.
.
/
.
4
.
/
0
.
.
/
0
4
.
/
1
.
.
/
1
4
Table 3: Robustness of correlation to variations in window size.
Window size 20 Mb 10 Mb 5 Mb 2 Mb 1 Mb
Actual annotation R = 0.40,
p < 4 × 10-4
R = 0.293,
p < 1 × 10-10
R = 0.256,
p < 1 × 10-10
R = 0.157,
p < 1 × 10-10
R = 0.154,
p < 1 × 10-10
Randomized annotation R = 0.02,
p = 0.58
R = 0.018,
p = 0.59
R = 0.058,
p = 0.11
R = 0.046,
p = 0.45
R = 0.035,
p = 0.01
Actual annotation, empty windows removed R = 0.11
p < 1 × 10-10
R = 0.11,
p < 1 × 10-10
Randomized annotation, empty windows removed R = 0.012,
p = 0.40
R = 0.020,
p = 0.83
Adjusting the window size does not eliminate the correlation between regions of conserved microsynteny and regions of high density of disease 
gene orthlogs. Randomization of gene annotations does eliminate the correlation at all window sizes except 1 Mb. However, when windows with 
no annotated genes are omitted from the analysis (bottom two rows), the correlation for actual annotations is improved at both 2 Mb and 1 Mb 
window sizes, and is eliminated for random annotations. As the genome does not have any windows lacking gene annotation for windows of 20 Mb, 
10 Mb, or 5 Mb, the correlation values could not be recalculated to omit annotation-free windows at those window sizes. R = Pearson's R.BMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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class are found in windows lacking any annotated genes.
When we remove all windows with no genes from our
analysis, the correlation between microsynteny conserva-
tion and disease gene density at 2 Mb and 1 Mb improves,
while the randomization trial correlation loses signifi-
cance (Table 3).
Discussion
We have examined the relationship between microsyn-
teny conservation and the density of orthologs of human
disease genes in the mouse genome. We found a correla-
tion between regions of conserved microsynteny and the
location of mouse orthologs of human disease genes,
which is consistent for variations in the window size used
in our analyses. The correlation we observe suggests that
regions of the mouse genome with a high density of dis-
ease gene orthologs undergo less rearrangement than
regions of the genome with fewer disease gene orthologs.
Genes associated with human disease are often ortholo-
gous to essential genes in other organisms [42]. Previous
studies from both mammals [29] and other eukaryotes
[24,26] have shown that essential genes are located in
highly conserved genomic regions. Thus, disease-related
genes, which perform essential functions, are more likely
to be found in conserved regions of the genome.
Several studies have found that at the sequence level,
human disease genes are more conserved than non-dis-
ease genes [26,43,44]. The sequence conservation of
human disease genes with essential C. elegans orthologs is
higher than those disease genes whose orthologs are not
lethal when mutated [44]. Interestingly, genes with high
polymorphism among humans, but no divergence
between humans and chimpanzees, are highly associated
with Mendelian disease [45]. Similarly, human disease
genes with weak negative selection, where mutant alleles
persist in the population, are more likely to cause diseases
with Mendelian inheritance [46]. Mendelian disease
genes are more constrained evolutionarily than disease
genes with non-Mendelian inheritance patterns [45].
Together, these observations support our finding that the
mouse orthologs of human disease genes are preferen-
tially found in genomic regions with high microsynteny
conservation.
Recombination may be mutagenic due to the possibility
of unequal crossing-over. Thus faulty recombination
events in regions with essential genes are likely to be del-
eterious to the survival of the organism and may thus be
selected against during mammalian evolution. Studies of
the human genome support this link between low recom-
bination and essential genes. Regions of the human
genome with high linkage disequilibrium, and thus low
recombination, are enriched for genes associated with
essential cellular functions such as response to DNA dam-
age, cell cycle progression, or DNA and RNA metabolism
[47]. Genes that show variation in populations, such as
immune response genes, are often found in regions with
low linkage disequilibrium, suggesting that recombina-
tion in these regions is not deleterious to the organism
[47]. Likewise, human genes found in mutation cold
spots tend to be genes involved in essential cellular proc-
esses, while those in mutation hot spots include immune
response genes [48]. These findings extend to non-coding
sequences as well, as human genomic regions that are
highly conserved with the pufferfish have been found to
contain enhancers for developmental genes [49].
The correlation between disease gene density and
microsynteny conservation, although significant, is not
perfect. Discrepancies may come from several sources. For
example, annotation of human disease genes is incom-
plete. Many housekeeping genes, which are likely to be
essential for mammalian development, are not annotated
as human disease genes, probably because mutations in
these genes are lethal early in development, and thus
humans with mutations are not viable [50]. The genomic
region between 55 - 75 Mb on mouse chromosome 3
Table 4: Number of windows in mouse genome at varying window sizes.
Window Size 20 Mb 10 Mb 5 Mb 2 Mb 1 Mb
Total windows 465 1912 3718 4897 24541
No annotated genes 000 2 3 7 2 7 6 1
No conserved genes 0 22 244 1211 9505
No disease genes 2 92 634 2160 14598
No disease or conserved 01 6 1 6 6 9 8 7 8 2 4 3
The number of windows with no annotations of genes, conserved genes, or disease orthologs is shown. Note that the bottom row shows the 
number of windows lacking both conserved and disease genes, which are a subset of the number of windows with either no disease genes or no 
conserved genes.BMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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shows high conservation but a low density of disease gene
orthologs. However, the genes Wwtr1  and  Shox2  are
located in this genomic region. A mouse knock-out of
Wwtr1  displays a phenotype resembling human poly-
cystic kidney disease [51], and the mouse knock-out of
Shox2 is lethal with cleft palate [52], strongly suggesting
that these genes are linked to human disease, although
neither is annotated as a disease gene in OMIM.
Likewise, many genes that are annotated as human dis-
ease genes may not be strictly essential for survival, and
thus these genes are not expected to have conserved
microsynteny. The genomic region between 85 - 105 Mb
on mouse chromosome 12 has a high density of disease
gene orthologs but low conservation. Mutations in the
human gene SERPINA10, whose ortholog is located in
this region, are associated with susceptibility to deep vein
thromboses [53]. Although SERPINA10 is annotated in
OMIM as a disease gene, it is unlikely that inherited muta-
tions in SERPINA10 present a challenge to survival of the
individual, suggesting that SERPINA10 does not represent
an essential gene. Finally, many diseases, especially can-
cers, are caused by translocation events that produce chi-
meric proteins. While a genomic region may have a great
density of disease loci due to translocations, these regions
would not show microsynteny conservation, as they are
high in rearrangements.
Discrepancies between microsynteny conservation and
the density of disease-related gene orthologs may also
arise because other factors contribute to selective pressure
on genome evolution. For example, previous studies have
suggested that mammalian genes are clustered into groups
based on co-expression [54,55]. It is proposed that gene
expression is therefore an evolutionary constraint on
genome organization, although the effect is weak as gene
clusters are found only slightly more often than by chance
[55]. There is also evidence that many over-lapping gene
pairs exist in mammalian genomes, and that these gene
pairs are conserved in multiple species, probably because
recombination or mutation in these regions of the
genome would cause deleterious mutations in both genes
[56]. Alternative mechanisms for the presence of essential
genes constraining genome structure have also been pro-
posed [24].
Conclusion
We have demonstrated the non-random distribution both
of genes with conserved microsynteny and genes with dis-
ease orthologs. This observation suggests that there are
constraints on genome organization in the mouse. More-
over, we have demonstrated that there is a correlation
between mammalian genome architecture and gene func-
tion. It is likely that this correlation arises from gene func-
tion constraining genome organization, resulting in
essential disease genes being located in regions of the
mammalian genome with high conservation. The identi-
fication of a correlation between microsynteny conserva-
tion and density of disease gene orthologs suggests that
additional experimental analysis of mouse genes in highly
conserved genomic regions will produce new mammalian
disease models by creating mutations in the orthologs of
human disease genes.
Methods
Microsynteny conservation
All protein coding genes on mouse autosomes were
retrieved using a BioMart search on the Ensembl Genome
Browser (http://www.ensembl.org/index.html, release 50,
NCBIM37 dataset). Orthologs of these genes in the
human, rat, and dog genomes, along with their genomic
positions, were retrieved using Ensembl BioMart homol-
ogy filters. Any mouse genes that did not have an ortholog
in another genome identified in BioMart were then sub-
jected to a BLAT search http://genome.ucsc.edu/cgi-bin/
hgBlat?command=start on the other genome using the
mouse protein sequence retrieved with the BioMart
sequences filter. The genomic location of the best match
to the mouse protein sequence from the second genome
was retrieved. Locally developed software was used to
identify genes with conserved microsynteny. Each mouse
gene is analyzed in turn. For each mouse gene m, its
neighbors in the mouse genome (m-1 and m+1) are iden-
tified. The orientation of m-1, m and m+1 is determined
from the start and stop positions. In the dog, human and
rat genomes, the homologue of m is identified from both
Ensembl BioMart homology filters and BLAT searches. We
term these homologues d, h and r. For each of these genes
their neighbors in their respective genomes (d-1, d+1, h-
1, h+1, r-1 and r+1) are identified, and their orientation
determined. The gene m is defined as having conserved
microsynteny only if all of the following are true: (i) m, d,
h, and r comprise a homologous set of genes (ii) m-1, d-
1, h-1 and r-1 comprise a homologous set (iii) m+1, d+1,
h+1 and r+1 comprise a homologous set (iv) the m, d, h,
and r have the same orientation (v) m-1, d-1, h-1 and r-1
have the same orientation and (iv) m+1, d+1, h+1 and r+1
have the same orientation. Results are robust whether or
not we limit the definition of conservation only to those
genes close to each other in the genome (within 200 Kb).
Results presented have conservation limited in this man-
ner.
Once conserved microsynteny had been defined for each
gene the percentage of genes with microsynteny was deter-
mined for 20 Mb intervals of the mouse genome, stag-
gered by a 5 Mb sliding window. To define the percentage
of microsynteny for a given window, the number of genes
with conserved synteny was divided by the total number
of genes in that window. The position of each gene wasBMC Genomics 2009, 10:521 http://www.biomedcentral.com/1471-2164/10/521
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chosen as the start site listed in Ensembl. For genes with
multiple transcripts, the position of the start site of the
longest transcript was used. The Shapiro-Wilk test was
applied to non-overlapping 20 Mb regions of the mouse
genome to determine whether the distribution gene
microsynteny was normal. Z-scores were calculated for
each region of the mouse genome using the equation:
Where x is the proportion of genes with conserved synteny
within each window, μ is the mean proportion of genes
with conserved synteny in all windows and s is the stand-
ard deviation of genes with conserved synteny in all win-
dows. Thus the Z-score represents the number of standard
deviations above or below the mean.
Comparison with sequence-based synteny blocks
Each highly conserved mouse genomic region was com-
pared to synteny maps based on sequence alignment.
Maps of the mouse compared to dog, rat, and human were
retrieved from the Ensembl genome browser (Compara-
tive Genomics - Synteny, http://www.ensembl.org/
Mus_musculus/Location/Synteny) database. Genomic
positions of synteny blocks were retrieved from the data-
base and tabulated.
Statistical analysis of conserved and disease gene pairs
Genes annotated as having conserved synteny or as dis-
ease orthologs were examined to determine whether the
following gene on the chromosome was similarly anno-
tated. The number of such gene pairs was determined per
chromosome. By this definition a run of three genes with
similar annotation would be counted as two pairs.
To determine the significance of the frequency of such
gene pairs, we compared the observed value to a random
distribution. The random distribution was calculated by
keeping the both the total number of genes and the
number of genes with a given annotation constant, but
randomizing the assignment of those annotations over
the total number of genes. The annotations were rand-
omized 10,000 times, and the number of neighbors with
similar annotations calculated. The significance of the
observed value was determined from this simulation i.e.
the likelihood of the observed value is the proportion of
random values that are greater than or equal to the
observed value.
Disease-related ortholog distribution
Human genes with a disease-associated mutant allele were
identified from the OMIM Morbid Map database http://
www.ncbi.nlm.nih.gov/Omim/getmorbid.cgi. These were
cross-referenced to the mouse genome using Ensembl
BioMart homology filters to identify mouse orthologs.
The distribution of disease-related gene orthologs was
analyzed by sliding window analysis, in the same manner
as for conserved synteny. For each 20 Mb window the
number of disease gene orthologs was divided by the total
number of genes in a window to determine the propor-
tion of disease gene orthologs in the window. Z-scores
were then calculated for each window using the equation
above.
Correlation analysis
The Pearson's correlation between the microsynteny con-
servation Z-scores and disease-related ortholog Z-scores
was calculated, and significance calculated using the chi-
squared test. As a control, we assigned new disease genes
at random for each chromosome, keeping the total
number of disease genes per chromosome the same. We
then recalculated the density of disease genes in each slid-
ing window throughout the genome. We plotted the Z-
scores for each window containing these alternate disease
orthologs, and compared them to the Z-scores for
microsynteny conservation. The Pearson's correlation was
then re-calculated, showing no significance for the alter-
nate set of disease genes. Correlation analysis was also
performed on window sizes of 10 Mb, staggered by 2.5
Mb, 5 Mb, staggered by 1.25 Mb, 2 Mb, staggered by 0.5
Mb, and 1 Mb, staggered by 0.25 Mb. Randomization tri-
als were performed on 10,000 random annotations for
each alternate window size as a control. To account for
windows with no genes at the window sizes of 2 Mb and
1 Mb, the correlation analysis was repeated with all win-
dows containing 0 genes removed from the actual and
randomized datasets.
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